Add to ORKGBackground: Little is known about CD4 cell count changes in patients with high CD4 cell counts who interrupt antiretroviral therapy, especially in those with a nadir of 250350 x 10(6) cells/I. Methods: Data derived from 139 patients from seven prospective cohorts who had > 12 months highly active antiretroviral therapy (HAART), CD4 cell count nadir of > 250 x 10(6) cells/I and at pre-interruption of > 500 x 106 cells/I. Endpoint was time to CD4 cell count 350 x 10(6) cells/I for a substantial period of time
OBJECTIVE: There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in r...
Objective: Few data describe antiretroviral treatment (ART)-related adverse events when treatment is...
There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in response to ...
Background: Little is known about CD4 cell count changes in patients with high CD4 cell counts who i...
Background: Little is known about CD4 cell count changes in patients with high CD4 cell counts who i...
BACKGROUND: Little is known about CD4 cell count changes in patients with high CD4 cell counts who i...
We studied the dynamics of CD4 cell counts after the interruption of virologically successful highly...
Background. The goal of the present study was to characterize outcome and predictors of outcome of t...
Background: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-lev...
International audienceABSTRACT: BACKGROUND: Changes in CD4 cell counts are poorly documented in indi...
In 115 patients whose scheduled treatment interruptions (STI) lasted 24 weeks, the CD4 cell count de...
Background: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-lev...
Patients who had started HAART (Highly Active Anti-Retroviral Treatment) under previous aggressive D...
BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...
Our objective was to study the evolution of CD4 cell count five years after starting highly active a...
OBJECTIVE: There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in r...
Objective: Few data describe antiretroviral treatment (ART)-related adverse events when treatment is...
There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in response to ...
Background: Little is known about CD4 cell count changes in patients with high CD4 cell counts who i...
Background: Little is known about CD4 cell count changes in patients with high CD4 cell counts who i...
BACKGROUND: Little is known about CD4 cell count changes in patients with high CD4 cell counts who i...
We studied the dynamics of CD4 cell counts after the interruption of virologically successful highly...
Background. The goal of the present study was to characterize outcome and predictors of outcome of t...
Background: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-lev...
International audienceABSTRACT: BACKGROUND: Changes in CD4 cell counts are poorly documented in indi...
In 115 patients whose scheduled treatment interruptions (STI) lasted 24 weeks, the CD4 cell count de...
Background: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-lev...
Patients who had started HAART (Highly Active Anti-Retroviral Treatment) under previous aggressive D...
BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...
Our objective was to study the evolution of CD4 cell count five years after starting highly active a...
OBJECTIVE: There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in r...
Objective: Few data describe antiretroviral treatment (ART)-related adverse events when treatment is...
There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in response to ...